Individuals and couples will have their own preference for a particular therapy, as it may suit their own sexual lifestyle. The majority of men will select a PDE5 inhibitor as their first treat’ ment of choice. Although the three currently available drugs in this class share a common mode of action, there are subtle pharmacO’ kinetic differences among them that may be of importance to the couple that is unrecognized by the physician. Read the rest of this entry »